Skip to content

A randomised open label study on potential effects of Ayurveda in schizophrenia

Potential effects of vamana and virechana karma in negative symptoms of schizophrenia-A randomised open label study - NA

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/08/056921
Enrollment
45
Registered
2023-08-25
Start date
Unknown
Completion date
Unknown
Last updated
2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F20- Schizophrenia

Interventions

None listed

Sponsors

DrAkhila Soman
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed patients of Unmada according to Ayurveda and patients of Schizophrenia as per DSM-5-TR Patients with predominant Negative symptoms (Any of the 4 Global scores of Scale for the Assessment of Negative Symptoms- SANS= 3). Mild or lesser level of positive symptoms (Global score of all items of Scale for the Assessment of Positive Symptoms SAPS Patients who are in the capacity to provide informed consent (as assessed by UBACC- University of California, San Diego Brief Assessment of Capacity to Consent (UBACC) will be recruited. Those who do not have the capacity, caregiver’s consent will be taken. Patients who are on stable medications for atleast 1 month.

Exclusion criteria

Exclusion criteria: Patients with bipolar affective disorder, substance use disorders (except nicotine and caffeine), major systemic illness, neurological disorders and immune system disorders. Patients with suicidal tendencies. Patients scoring > 7 in Hamilton Depression Rating Scale. Pregnant and lactating mothers. Patients unsuitable for Vamana procedure – heart diseases, severe hepatic, renal or pulmonary dysfunction. Patients who have undergone Vamana or Virechana karma in the last 3 months.

Design outcomes

Primary

MeasureTime frame
To evaluate clinical efficacy of Vamana and Virechana karma in patients of Schizophrenia with predominant negative symptoms, in comparison to treatment as usual group using Scale for assessment of Positive Symptoms (SAPS) and Scale for assessment of Negative Symptoms(SANS) Timepoint: Baseline, after 3 days of intervention and after 1 month of intervention

Secondary

MeasureTime frame
a) To study the effect of Vamana & Virechana karma on functioning, physical health (BMI), acute changes in physiological (CRP & HRV) parameters after 3 days of vamana/virechana karma in patients of Schizophrenia with predominant negative symptoms b) To evaluate the sustenance of improvement in terms of physical health (BMI), acute changes in physiological (CRP & HRV) after 1 month of Vamana & Virechana karma in patients of Schizophrenia with predominant negative symptoms.Timepoint: Baseline, after 3 days of intervention & after 1 month of intervention

Countries

India

Contacts

Public ContactDrAkhila Soman

NIMHANS

ayurkishore@yahoo.com9845829174

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026